TB-500's angiogenic effects address the vascular limitations that slow tendon healing
Today's oral GLP-1s give 13-15% weight loss at 36 weeks (orforglipron Phase 2)
Monitor electrolyte levels, particularly potassium, and replace electrolytes as indicated to maintain balance and prevent dysrhythmias
PubMed, Kim, Minyoung, et al
Sleep improvements are typically the first change patients notice
In parallel with the above observations, the use of GSH in a combination treatment of MRAB especially with an antibiotic (at highest concentration, 5 MBC) resulted in the lowest recoverable CFU count (i.e., the lowest level of viability) (Figure 6)